Entrada Therapeutics Inc - TRDA - stock price prediction, stock price target, analyst ratings from 4 analysts

Entrada Therapeutics Inc has a share price target of US$ 18, revenue growth forecast of -83.8%, and profit growth estimate of -325.4% for FY25, based on top 4 analyst calls.